Your bloating isn’t from ‘low stomach acid’ - this is a popular wellness claim with almost no clinical basis; most bloating is motility or fermentation-related, not acid-related.
Bloating after every meal isn’t ‘just IBS’- persistent post-meal bloating gets dismissed as IBS when it’s sometimes SIBO, gastroparesis, or pancreatic insufficiency - distinct conditions with different treatments.
Think gluten is the problem?
It might be fructans.
They're found in wheat, garlic, and onions—and can cause the same bloating.
Still bloated after going gluten-free? Check your garlic and onion intake.
Healthy meal. Bloated 30 minutes later?
It may not be the food.
Fast fermentation higher in the gut can cause gas and bloating.
The fix isn't less fiber - it's slower fermentation.
Think: smaller portions, cooked foods, acacia, or PHGG.
Pancreatic cancer used to be an older person’s disease.
Cases are now rising in younger adults - especially women - driven by obesity, diabetes, and smoking. 
Know your risk. Modify what you can. Catch it early.
That’s the only path to better outcomes.
Pancreatic cancer kills because it looks like everything else.
What gets missed:
Jaundice
Unexplained weight loss
Back and abdominal pain
New-onset diabetes
Light-colored stools 
New diabetes after 50 + weight loss = imaging. No exceptions.
Pancreatic cancer has a 13% five-year survival rate.
It’s the only major cancer still below 20%.
Here’s why - and what needs to change.
Most people are diagnosed too late for surgery.
Catch it early? Survival jumps to 46%. 
That gap is the whole story.
70,000 Americans are diagnosed with pancreatic cancer each year. Most learn too late.
This week at ASCO, a daily pill nearly doubled survival for advanced patients.
For a cancer with almost no good options, that’s huge.
Pancreatic cancer has a ~3% 5-year survival rate once it spreads.
Now a daily pill, daraxonrasib, cut the risk of death by 60% in metastatic disease.
Median survival: 13.2 vs 6.7 months.
Not a cure. But real progress against one of medicine’s toughest cancers.
Breaking: Daraxonrasib just became the first pill to double survival in advanced pancreatic cancer. 13 months vs. 6 on chemo. Not a cure - but the biggest leap this disease has ever seen.